Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Sunday, March 15, 2015

Experimental cholesterol drugs cut heart risk, but questions remain

Big F*CKING WHOOPEE
Replacing one class of cholesterol lowering drugs with another is pure stupidity. They aren't even addressing the correct problem. Inflammation! If there was no inflammation it wouldn't grab the cholesterol out of the bloodstream and pack it into plaque. Do these people never read research? Or understand anything about cause and effect? Leaders would tackle the hardest problems. Alas, we have no leaders in stroke. Kiss your neurons goodbye if you have a stroke.
Statins cause enough problems without going to a new drug that might rarely cause
neurocognitive problems.
You can see a video of how plaque forms here:
Inflammation In Atherosclerotic Plaque Formation  


 Experimental cholesterol drugs cut heart risk, but questions remain 
Studies of a new class of experimental cholesterol-lowering drugs signal that they may reduce by half the risk of heart attack and other major cardiovascular problems compared to standard treatment alone.
Doctors at the annual meeting of the American College of Cardiology, where the studies were presented, called the results "encouraging," but said larger, controlled trials were needed to fully understand the drugs, known as PCSK9 inhibitors.
An analysis of about 4,500 patients who continued treatment for nearly a year after completing earlier trials of Amgen Inc's Repatha, also known as evolocumab, found that 0.95 percent of patients given the drug and standard therapy suffered a cardiovascular event, compared with 2.18 percent of the group receiving standard treatment, which ranged from dietary changes to drugs such as statins.
Amgen defined "event" in the study as death, heart attack, stroke or "mini-stroke," unstable chest pain or heart failure requiring hospitalization, or the need for a procedure to restore bloodflow to the heart.
Side effects more frequent, but still rare, in patients treated with Repatha included neurocognitive problems - something the U.S. Food and Drug Administration has said should be monitored closely.

More at link.

No comments:

Post a Comment